Pfizer/BioNTech mRNA Combo Influenza and COVID Shot Efficacy Fails in Trial
Pfizer and BioNTech recently announced that a new mRNA vaccine designed to protect against both COVID-19 and influenza in a single shot faced a major setback after failing to achieve one of its primary goals in a late-stage trial. The “primary goal” missed in the late-stage trials was the ability to effectively prevent influenza B. […]
